Literature DB >> 23154483

Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease.

Valerio Nobili1, Mariacristina Siotto, Giorgio Bedogni, Lucilla Ravà, Andrea Pietrobattista, Nadia Panera, Anna Alisi, Rosanna Squitti.   

Abstract

OBJECTIVES: Nonalcoholic fatty liver disease (NAFLD) in adolescents and children is rapidly becoming one of the most common causes of chronic liver disease worldwide. NAFLD varies from simple fatty liver to nonalcoholic steatohepatitis (NASH) with possible fibrosis. Several studies suggest that oxidative stress plays a central role in several metabolic abnormalities and cellular damage that characterize NAFLD. We investigated whether transition metals and their related proteins were related to NAFLD symptoms and their underlying processes.
METHODS: We measured copper, iron, ceruloplasmin (Cp) concentration and activity, transferrin (Tf), ferroxidase activity, and ferritin, and we calculated Tf saturation and Cp to Tf ratio (Cp/Tf) as an index of the activity of the antioxidant Cp-Tf system in 100 children with biopsy-proven NAFLD. Pediatric patients were grouped by nonalcoholic fatty liver disease score (NAS) ≥ 5 (30 subjects) and NAS < 5 (70).
RESULTS: Cp distinguished children with NAS ≥ 5 from those with NAS < 5 with an accuracy of 82%. Specifically, a receiver operator characteristics curve showed that a cutoff of 28.6 mg/dL separated NAS ≥ 5 from NAS < 5 with a specificity of 92% and a sensitivity of 76%. The Cp/Tf ratio, as well as copper concentration and Cp activity, decreased in the NAS ≥ 5 group, pointing out an imbalance in metal regulation. Either copper or Cp concentrations were lower in subjects having ballooning.
CONCLUSIONS: Serum antioxidant capacity owing to Cp failure is strongly associated with NAFLD-related damage. Further studies are, however, required to clarify the role of Cp in NAFLD pathogenesis and to evaluate its potential application as diagnostic marker.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23154483     DOI: 10.1097/MPG.0b013e31827aced4

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  20 in total

1.  An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain.

Authors:  Mariacristina Siotto; Irene Aprile; Ilaria Simonelli; Costanza Pazzaglia; Mariacarla Ventriglia; Massimo Santoro; Isabella Imbimbo; Rosanna Squitti; Luca Padua
Journal:  J Neural Transm (Vienna)       Date:  2017-10-30       Impact factor: 3.575

2.  Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.

Authors:  Savannah Tallino; Megan Duffy; Martina Ralle; María Paz Cortés; Mauricio Latorre; Jason L Burkhead
Journal:  J Nutr Biochem       Date:  2015-05-15       Impact factor: 6.048

3.  Metabolic dysregulation in the Atp7b -/- Wilson's disease mouse model.

Authors:  Clavia Ruth Wooton-Kee; Matthew Robertson; Ying Zhou; Bingning Dong; Zhen Sun; Kang Ho Kim; Hailan Liu; Yong Xu; Nagireddy Putluri; Pradip Saha; Cristian Coarfa; David D Moore; Alli M Nuotio-Antar
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-10       Impact factor: 11.205

4.  Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).

Authors:  Christina M Parrinello; Bryan J Rudolph; Mariana Lazo; Linda C Gallo; Bharat Thyagarajan; Scott J Cotler; Qibin Qi; Tossaporn Seeherunvong; Denise C Vidot; Howard D Strickler; Robert C Kaplan; Carmen R Isasi
Journal:  J Clin Gastroenterol       Date:  2019-02       Impact factor: 3.062

Review 5.  Biomarkers in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Lawrence B Cohen; Radu M Nanau
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

6.  Obesity is associated with copper elevation in serum and tissues.

Authors:  Haojun Yang; Chin-Nung Liu; Risa M Wolf; Martina Ralle; Som Dev; Hannah Pierson; Frederic Askin; Kimberley E Steele; Thomas H Magnuson; Michael A Schweitzer; G William Wong; Svetlana Lutsenko
Journal:  Metallomics       Date:  2019-06-28       Impact factor: 4.526

7.  Hepatic Steatosis in the Mouse Model of Wilson Disease Coincides with a Muted Inflammatory Response.

Authors:  Aline Gottlieb; Som Dev; Lauren DeVine; Kathleen L Gabrielson; Robert N Cole; James P Hamilton; Svetlana Lutsenko
Journal:  Am J Pathol       Date:  2021-10-08       Impact factor: 4.307

8.  A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population.

Authors:  Qingling Wang; Da Zhou; Mingjie Wang; Mingyu Zhu; Peizhan Chen; Hu Li; Meng Lu; Xinxin Zhang; Xizhong Shen; Taotao Liu; Li Chen
Journal:  Front Med (Lausanne)       Date:  2022-06-20

Review 9.  The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease.

Authors:  Alexandra Feldman; Elmar Aigner; Daniel Weghuber; Katharina Paulmichl
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

10.  Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders.

Authors:  Pornwilard M-M; Ralf Weiskirchen; Nikolaus Gassler; Anja K Bosserhoff; J Sabine Becker
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.